The significantly high expression of HNRNPA2B1 in the lung sample of MCT-PAH (Figure 9B) compared with controls (Figure 9A) was confirmed using immunohistochemistry. The gene discussed is HNRNPA2B1; the disease is pulmonary arterial hypertension.